Risk factors

What each company says could go wrong in its 10-K, and what changed since last year: the risks added, dropped and rewritten.

7,691 annual reports · 4,011 companies

Readings are automated and can be wrong; check the filing for the exact wording.

Older filings

Page 217 of 641 · 7,691 filings

  • Goldman Sachs Group (GS) FY2025 10-K risk factors
    45 risks2 dropped9 reworded

    Climate risks now explicitly include conflicting legal requirements and stakeholder expectations around climate matters.

    Filed Feb 25, 2026
  • Bank of America (BAC) FY2025 10-K risk factors
    34 risks7 new5 dropped19 reworded

    New risks emphasize subsidiary funding constraints, cross-border fragmentation, third-party operational and cybersecurity vulnerabilities, and evolving regulation.

    Filed Feb 25, 2026
  • BlackRock (BLK) FY2025 10-K risk factors
    47 risks1 dropped12 reworded

    Acquisition integration is more prominent: GIP and HPS benefits, synergies and management distraction are now explicit.

    Filed Feb 25, 2026
  • UNITED Therapeutics (UTHR) FY2025 10-K risk factors
    32 risks2 new6 dropped10 reworded

    Drug-pricing pressure now includes the 2025 Part D redesign, Medicaid reductions, possible tariffs, and most-favored-nation pricing demands.

    Filed Feb 25, 2026
  • ADMA Biologics (ADMA) FY2025 10-K risk factors
    54 risks3 new1 dropped18 reworded

    Refinancing replaced Ares credit facilities with a larger $300 million JPMorgan credit agreement. AI adoption introduced new operational and reputational risks regarding ADMAlytics. Regulatory and legal uncertainties grew following 2025 federal changes and Supreme Court rulings.

    Filed Feb 25, 2026
  • American Financial Group (AFG) FY2025 10-K risk factors
    30 risks2 new10 reworded

    AFG added specific operational risks around artificial intelligence usage and regulatory capital admissibility for alternative investments.

    Filed Feb 25, 2026
  • Aflac (AFL) FY2025 10-K risk factors
    27 risks4 new2 dropped8 reworded

    Aflac Japan continues to represent the vast majority of assets and revenues, creating heavy reliance on the yen-dollar exchange rate and hedging strategies.

    Filed Feb 25, 2026
  • agilon health (AGL) FY2025 10-K risk factors
    57 risks4 new5 dropped9 reworded

    Agilon health faces new risks regarding NYSE delisting threat and corporate practice of medicine regulatory inquiries. The company plans a reverse stock split to regain compliance with NYSE price criteria. Ongoing legal challenges now include stockholder derivative lawsuits alongside existing class actions.

    Filed Feb 25, 2026
  • Alkermes (ALKS) FY2025 10-K risk factors
    43 risks4 new3 dropped11 reworded

    Integration risks and $1.525 billion debt from the Avadel acquisition dominate the updated risk factors.

    Filed Feb 25, 2026
  • Ally Financial (ALLY) FY2025 10-K risk factors
    45 risks5 new5 dropped21 reworded

    Ally Financial added new risks covering artificial intelligence adoption, conflicting climate disclosure mandates, and anti-takeover provisions.

    Filed Feb 25, 2026
  • APi Group (APG) FY2025 10-K risk factors
    51 risks6 new3 dropped8 reworded

    The company highlights new operational risks regarding ERP system implementations and cloud computing migrations. Expansion through acquisitions and divestitures remains a core focus with added structural scrutiny. Cybersecurity disclosures now explicitly cover operational technology systems and customer-site equipment.

    Filed Feb 25, 2026
  • Apollo Global Management (APO) FY2025 10-K risk factors
    38 risks5 new8 dropped12 reworded

    Apollo added new risk disclosures regarding debt restrictions and tax audits. Fund raising pressures and artificial intelligence competition risks were modified.

    Filed Feb 25, 2026

Companies covered

4,011 companies

371 more under A